Margaret Ekins Smith - Chief Commercial Officer at ARS Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Chief Commercial Officer
Issuer ticker
SPRY on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Margaret Ekins Smith since 20 Sep 2025

Reported holdings for Margaret Ekins Smith in ARS Pharmaceuticals, Inc.

Form 4 holding Chief Commercial Officer

ARS Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
1,001,738
Estimated value
Report date
01 Sep 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Margaret Ekins Smith in ARS Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .